KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Cash & Equivalents (2016 - 2025)

Stereotaxis (STXS) has disclosed Cash & Equivalents for 16 consecutive years, with $10.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 1.47% to $10.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.5 million, a 1.47% decrease, with the full-year FY2024 number at $12.2 million, down 38.35% from a year prior.
  • Cash & Equivalents was $10.5 million for Q3 2025 at Stereotaxis, up from $7.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $42.5 million in Q1 2021 to a low of $5.6 million in Q1 2023.
  • A 5-year average of $22.7 million and a median of $19.8 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 83.98% in 2023, then skyrocketed 224.49% in 2024.
  • Stereotaxis' Cash & Equivalents stood at $40.1 million in 2021, then tumbled by 78.61% to $8.6 million in 2022, then surged by 130.82% to $19.8 million in 2023, then crashed by 38.35% to $12.2 million in 2024, then fell by 14.01% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Cash & Equivalents are $10.5 million (Q3 2025), $7.0 million (Q2 2025), and $10.7 million (Q1 2025).